Related references
Note: Only part of the references are listed.Kynurenine catabolic enzyme KMO regulates HCC growth
Zhaopeng Shi et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers
Disala Fernando et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system
Moein Ala
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2022)
Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR/Ca2+ influx and CaMKII/IRF3-mediated IFN-β production
Jin Zhao et al.
PLOS PATHOGENS (2022)
Kynurenine3-monooxygenase(KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma
I-Li Liu et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2021)
Current and emerging therapeutic targets for Parkinson's disease
Tanvi Pingale et al.
METABOLIC BRAIN DISEASE (2021)
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease
Luke Whiley et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
New frontiers in flavin-dependent monooxygenases
Renata A. G. Reis et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors
Hidenori Kimura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Flavoprotein monooxygenases: Versatile biocatalysts
Caroline E. Paul et al.
BIOTECHNOLOGY ADVANCES (2021)
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease
Marie Katrin Bondulich et al.
SCIENTIFIC REPORTS (2021)
Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
Shinya Mimasu et al.
COMMUNICATIONS BIOLOGY (2021)
Discovery of N-(6-(5-fluoro-2-(piperidin-1-yl)phenyl) pyridazin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)methanesulfonamide as a brain-permeable and metabolically stable kynurenine monooxygenase inhibitor
Katsunori Tsuboi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway
Yi Luo et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers
Yuk-Wah Tsang et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
Chun-Yu Liu et al.
FRONTIERS IN ONCOLOGY (2021)
The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications
Tapan Behl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease
Li-Ming Chen et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
Amira Ben Afia et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase
Lizaveta Gotina et al.
MOLECULES (2021)
Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas
Gustavo Ignacio Vazquez Cervantes et al.
CELLS (2021)
Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers
Min-Hua Lai et al.
CANCER CONTROL (2021)
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler et al.
MOLECULAR PSYCHIATRY (2020)
Modification of kynurenine pathway via inhibition of kynurenine hydroxylase attenuates surgical brain injury complications in a male rat model
George Zakhary et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
Arghya Ray et al.
LEUKEMIA (2020)
IDO activation, inflammation and musculoskeletal disease
Joy Ogbechi et al.
EXPERIMENTAL GERONTOLOGY (2020)
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2020)
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Yi-Shu Huang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis et al.
PSYCHOPHARMACOLOGY (2020)
Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation
Min-Jung You et al.
TRANSLATIONAL PSYCHIATRY (2020)
Kynurenine 3-monooxygenase upregulates pluripotent genes through beta-catenin and promotes triple-negative breast cancer progression
Tzu-Ting Huang et al.
EBIOMEDICINE (2020)
Kynurenine pathway enzyme KMO in cancer progression: A tip of the Iceberg
So-Yeon Park et al.
EBIOMEDICINE (2020)
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
Gayathri Sundaram et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Parkinson's disease: etiopathogenesis and treatment
Joseph Jankovic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Hydrogen movements in the oxidative half-reaction of kynurenine 3-monooxygenase from Pseudomonas fluorescens reveal the mechanism of hydroxylation
Brett A. Beaupre et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nora Torok et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
Benjamin Heng et al.
BREAST CANCER RESEARCH (2020)
In silico methods predict new blood-brain barrier permeable structure for the inhibition of kynurenine 3-monooxygenase
Yilmaz Ozkilic et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
Sarah J. Tabrizi et al.
NEURON (2019)
Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors
Yi-Han Chiu et al.
JOURNAL OF ONCOLOGY (2019)
Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease
Freek J. H. Sorgdrager et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis
Charles C. N. Wang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Yu Chen et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Chiral cyclopentadienyl RhIII-catalyzed enantioselective cyclopropanation of electron-deficient olefins enable rapid access to UPF-648 and oxylipin natural products
Coralie Duchemin et al.
CHEMICAL SCIENCE (2019)
Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
Robert S. Phillips et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
Shaowei Zhang et al.
COMMUNICATIONS BIOLOGY (2019)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048
Jingjing Gao et al.
FASEB JOURNAL (2018)
Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens
Pablo Gimenez-Gomez et al.
NEUROPHARMACOLOGY (2018)
The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Reus et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation
Allison M. Garrison et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions
Hassan A. Aziz et al.
FRONTIERS IN GENETICS (2018)
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
Hyun Tae Kim et al.
CELL CHEMICAL BIOLOGY (2018)
Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques
Steven Shave et al.
ACS OMEGA (2018)
DNA-encoded chemistry: enabling the deeper sampling of chemical space
Robert A. Goodnow et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis
Ann L. Walker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz et al.
NEUROPHARMACOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture
Daniela Ramirez-Ortega et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Chai K. Lim et al.
PROGRESS IN NEUROBIOLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
Jonathan P. Hutchinson et al.
NATURE COMMUNICATIONS (2017)
Evaluation of Tryptophan/Kynurenine Pathway Relevance With Immune System Biomarkers of Low Energy Trauma Hip Fractures in Osteoporotic Patients
Ercan Dincel et al.
ARCHIVES OF RHEUMATOLOGY (2017)
Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders
Sophie Erhardt et al.
BIOLOGICAL PSYCHIATRY (2017)
Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain
Geoffroy Laumet et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
Jason R. Smith et al.
DRUG DISCOVERY TODAY (2016)
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
Vahri Beaumont et al.
EXPERIMENTAL NEUROLOGY (2016)
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
Damian J. Mole et al.
NATURE MEDICINE (2016)
KMO inhibitor for multi-organ failure in experimental acute pancreatitis
Katrina Ray
Nature Reviews Gastroenterology & Hepatology (2016)
Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model
Ewelina Rojewska et al.
NEUROPHARMACOLOGY (2016)
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
Carlo Breda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Michael D. Lovelace et al.
FRONTIERS IN IMMUNOLOGY (2016)
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Amy B. Dounay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington's Disease
Leticia M. Toledo-Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
Haojie Jin et al.
SCIENTIFIC REPORTS (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Kynurenine 3-monooxygenase: an influential mediator of neuropathology
Jennifer M. Parrott et al.
FRONTIERS IN PSYCHIATRY (2015)
Flavin dependent monooxygenases
Mieke M. E. Huijbers et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
C. Lavebratt et al.
MOLECULAR PSYCHIATRY (2014)
Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA RESEARCH (2014)
Lead Discovery for Human Kynurenine 3-Monooxygenase by High-Throughput RapidFire Mass Spectrometry
Denise M. Lowe et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls
Markus J. Schwarz et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands
Geoffrey L. Stephens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Targeted Deletion of Kynurenine 3-Monooxygenase in Mice A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN
Flaviano Giorgini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: Cytokine challenge increases production of 3-hydroxykynurenine
Anne-Sofie Johansson et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Structural basis of kynurenine 3-monooxygenase inhibition
Marta Amaral et al.
NATURE (2013)
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
Michael D. Gershon
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)
Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata
Yunjiang Feng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Form Follows Function: Structural and Catalytic Variation in the Class A Flavoprotein Monooxygenases
Karen Crozier-Reabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048
Maria G. Beconi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
Susanna Campesan et al.
CURRENT BIOLOGY (2011)
N-Formylkynurenine as a Marker of High Light Stress in Photosynthesis
Tina M. Dreaden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy
Daniela Silva-Adaya et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
Molly K. Larson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Targeting the Progression of Parkinson's Disease
J. L. George et al.
CURRENT NEUROPHARMACOLOGY (2009)
Identification of a novel conserved sequence motif in flavoprotein hydroxylases with a putative dual function in FAD/NAD(P)H binding
Michel H. M. Eppink et al.
PROTEIN SCIENCE (2009)
Kynurenine 3-Monooxygenase from Pseudomonas fluorescens: Substrate-like Inhibitors both Stimulate Flavin Reduction and Stabilize the Flavin-Peroxo Intermediate yet Result in the Production of Hydrogen Peroxide
Karen R. Crozier-Reabe et al.
BIOCHEMISTRY (2008)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase
J Breton et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: Potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents
MJ Drysdale et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
